Endonovo Therapeutics Inc (ENDV)

[Doyle McBoyle1]

ENDV is so close to breaking out, once distribution for sofpulse is established it can be used as another reason for an institutional investor to come in, whichever happens first is gonna be a major stepping stone because shortly after there won’t be a need for all these “toxic loans”, revenue and investors will create a decent amount of the capital needed to move forward with patents, clinical trials, etc. This also requires ENDV to get a fire lit under there ass cause really, the shareholders have been very patient and personally I want to see ENDV take action, not sending emails on what they’re working on, I want check marks as in things are getting done